Gland Chemicals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 4.78 Cr
as on 27-06-2024
- Company Age 50 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.30 Cr
as on 27-06-2024
- Satisfied Charges ₹ 28.45 Cr
as on 27-06-2024
- Revenue 32.53%
(FY 2022)
- Profit -68.68%
(FY 2022)
- Ebitda -32.17%
(FY 2022)
- Net Worth 13.94%
(FY 2022)
- Total Assets 115.99%
(FY 2022)
About Gland Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.78 Cr.
The company currently has active open charges totaling ₹16.30 Cr. The company has closed loans amounting to ₹28.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Penmetsa Ravindranath, Nakul Penmetsa, Viswanath Chibrolu, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24110TG1974PTC001694
- Company No.
001694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 1974
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gland Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Bandreddi  | Managing Director | 01-Nov-2012 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Penmetsa Ravindranath  | Director | 07-Feb-1983 | Current |
| Nakul Penmetsa | Director | 01-Nov-2012 | Current |
| Viswanath Chibrolu | Director | 14-Nov-2022 | Current |
| Ramesh Penmetcha | Director | 26-Dec-2018 | Current |
Financial Performance and Corporate Structure Insights of Gland Chemicals.
Gland Chemicals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 32.53% increase. The company also saw a substantial fall in profitability, with a 68.68% decrease in profit. The company's net worth Soared by an impressive increase of 13.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gland Chemicals?
In 2022, Gland Chemicals had a promoter holding of 97.37% and a public holding of 2.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nr Advisory Services LlpActive 9 years 3 months
Penmetsa Ravindranath and Nakul Penmetsa are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
A.P.I.D.C. Creation Date: 20 Mar 1997 | ₹2.99 M | Open |
Axis Bank Limited Creation Date: 14 Mar 1996 | ₹16.00 Cr | Open |
Technology Development Board Creation Date: 09 Dec 2011 | ₹8.60 Cr | Satisfied |
How Many Employees Work at Gland Chemicals?
Gland Chemicals has a workforce of 360 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gland Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gland Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
